Helen Stevenson



Helen Stevenson is Founder and Chief Executive Officer of Reformulary Group Inc., a healthcare tech company that built an evidence-based drug list that saves companies money and helps Canadians make smart drug choices through its DrugFinder™ app. The company recently launched Cannabis Standard™, a technology platform that provides expert advice related to the use of medical cannabis, as well as a research platform that will allow users to contribute their real-world outcomes. Reformulary Group also offers health and drug data analytics solutions.

Helen is the former Assistant Deputy Minister of Health and Executive Officer of Ontario Public Drug Programs, responsible for the Province’s $4 billion publicly funded drug programs. Prior to that Helen was Founder and President of Savattuq Inc., a healthcare consultancy in Toronto and previously in Zurich, Switzerland.

She is on the Board of Directors of the Centre for Effective Practice. Helen was a founding Trustee of the Auto Sector Retiree Health Care Trust (asrTrust), and has also served on the Board of Directors of North York General Hospital and the Toronto East General Hospital Foundation.

Helen holds a Bachelor of Commerce degree from McGill University, Montreal, Canada and a Master of Science in Management from Boston University Brussels. She holds the ICD.D designation. Helen has lived and worked in Canada, Belgium, and Switzerland.